SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-364347
Filing Date
2015-11-03
Accepted
2015-11-03 16:24:09
Documents
16
Period of Report
2015-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d96091d6k.htm 6-K 240287
2 GRAPHIC g96091im006.jpg GRAPHIC 225290
3 GRAPHIC g96091img001.jpg GRAPHIC 267154
4 GRAPHIC g96091img002.jpg GRAPHIC 351331
5 GRAPHIC g96091img003.jpg GRAPHIC 266692
6 GRAPHIC g96091img004.jpg GRAPHIC 250149
7 GRAPHIC g96091img005.jpg GRAPHIC 218553
8 GRAPHIC g96091img007.jpg GRAPHIC 197889
9 GRAPHIC g96091img008.jpg GRAPHIC 170802
10 GRAPHIC g96091img009.jpg GRAPHIC 201416
11 GRAPHIC g96091img010.jpg GRAPHIC 228741
12 GRAPHIC g96091img011.jpg GRAPHIC 375602
13 GRAPHIC g96091img012.jpg GRAPHIC 183070
14 GRAPHIC g96091img013.jpg GRAPHIC 285583
15 GRAPHIC g96091img014.jpg GRAPHIC 227695
16 GRAPHIC g96091img015.jpg GRAPHIC 240222
  Complete submission text file 0001193125-15-364347.txt   5326014
Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Filer) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-33623 | Film No.: 151194003
SIC: 2834 Pharmaceutical Preparations